Loading…
Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8
Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transfor...
Saved in:
Published in: | Food and chemical toxicology 2015-10, Vol.84, p.250-259 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53 |
---|---|
cites | cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53 |
container_end_page | 259 |
container_issue | |
container_start_page | 250 |
container_title | Food and chemical toxicology |
container_volume | 84 |
creator | He, Jian Wei Bondy, Genevieve S. Zhou, Ting Caldwell, Don Boland, Greg J. Scott, Peter M. |
description | Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON.
•The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice. |
doi_str_mv | 10.1016/j.fct.2015.09.003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762369692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278691515300545</els_id><sourcerecordid>1762369692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</originalsourceid><addsrcrecordid>eNqNkU9r3DAQxUVJaTZpP0AvRcccKnck2ZJMTyH_Wgj0kp6FLI-LFtvaSvaS_fZV2LTQS8hpYOY3j5n3CPnIoeLA1ZdtNfilEsCbCtoKQL4hG260ZEo2_IRsQGjDVMubU3KW8xYANNfqHTkVSiopwWzI8BAfg49j_HWgcaCS4S6wHuPjYQ57N-Icx8_U0f87bEluzkNMk1tCnOkuxX71C-0O9Br3MQdHp3UpCOWaCXbDzHvydnBjxg_P9Zz8vL15uPrG7n_cfb-6vGe-lvXCjIO6aaUxjRz0oHrFO2E8aCcEqMa32unad53zZSi7WgH3Brl2WHvVCGzkObk46paTfq-YFzuF7HEc3Yxxzba8L6RqVStegXJTrCsWFpQfUZ9izgkHu0thculgOdinJOzWliTsUxIWWluSKDufnuXXbsL-38Zf6wvw9Qhg8WMfMNnsA84e-5CwiPUxvCD_B_mjmFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718915278</pqid></control><display><type>article</type><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><source>Elsevier</source><creator>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</creator><creatorcontrib>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</creatorcontrib><description>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON.
•The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</description><identifier>ISSN: 0278-6915</identifier><identifier>EISSN: 1873-6351</identifier><identifier>DOI: 10.1016/j.fct.2015.09.003</identifier><identifier>PMID: 26363308</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>3-epi-DON ; 3T3 fibroblasts cell line ; Administration, Oral ; Animals ; B6C3F1 mouse ; BrdU bioassay ; Caco-2 cell line ; Caco-2 Cells ; Cell Survival - drug effects ; Crosses, Genetic ; Cytotoxicity ; Deoxynivalenol ; Devosia ; DNA - biosynthesis ; DON ; Dose-Response Relationship, Drug ; Female ; Humans ; Hyphomicrobiaceae - metabolism ; Inactivation, Metabolic ; Kinetics ; Mice ; MTT bioassay ; NIH 3T3 Cells ; Nucleic Acid Synthesis Inhibitors - administration & dosage ; Nucleic Acid Synthesis Inhibitors - chemistry ; Nucleic Acid Synthesis Inhibitors - metabolism ; Nucleic Acid Synthesis Inhibitors - toxicity ; Random Allocation ; Stereoisomerism ; Toxicity Tests, Subacute ; Trichothecenes - administration & dosage ; Trichothecenes - chemistry ; Trichothecenes - metabolism ; Trichothecenes - toxicity ; Vomitoxin</subject><ispartof>Food and chemical toxicology, 2015-10, Vol.84, p.250-259</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</citedby><cites>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26363308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Jian Wei</creatorcontrib><creatorcontrib>Bondy, Genevieve S.</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>Caldwell, Don</creatorcontrib><creatorcontrib>Boland, Greg J.</creatorcontrib><creatorcontrib>Scott, Peter M.</creatorcontrib><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><title>Food and chemical toxicology</title><addtitle>Food Chem Toxicol</addtitle><description>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON.
•The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</description><subject>3-epi-DON</subject><subject>3T3 fibroblasts cell line</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>B6C3F1 mouse</subject><subject>BrdU bioassay</subject><subject>Caco-2 cell line</subject><subject>Caco-2 Cells</subject><subject>Cell Survival - drug effects</subject><subject>Crosses, Genetic</subject><subject>Cytotoxicity</subject><subject>Deoxynivalenol</subject><subject>Devosia</subject><subject>DNA - biosynthesis</subject><subject>DON</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Humans</subject><subject>Hyphomicrobiaceae - metabolism</subject><subject>Inactivation, Metabolic</subject><subject>Kinetics</subject><subject>Mice</subject><subject>MTT bioassay</subject><subject>NIH 3T3 Cells</subject><subject>Nucleic Acid Synthesis Inhibitors - administration & dosage</subject><subject>Nucleic Acid Synthesis Inhibitors - chemistry</subject><subject>Nucleic Acid Synthesis Inhibitors - metabolism</subject><subject>Nucleic Acid Synthesis Inhibitors - toxicity</subject><subject>Random Allocation</subject><subject>Stereoisomerism</subject><subject>Toxicity Tests, Subacute</subject><subject>Trichothecenes - administration & dosage</subject><subject>Trichothecenes - chemistry</subject><subject>Trichothecenes - metabolism</subject><subject>Trichothecenes - toxicity</subject><subject>Vomitoxin</subject><issn>0278-6915</issn><issn>1873-6351</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkU9r3DAQxUVJaTZpP0AvRcccKnck2ZJMTyH_Wgj0kp6FLI-LFtvaSvaS_fZV2LTQS8hpYOY3j5n3CPnIoeLA1ZdtNfilEsCbCtoKQL4hG260ZEo2_IRsQGjDVMubU3KW8xYANNfqHTkVSiopwWzI8BAfg49j_HWgcaCS4S6wHuPjYQ57N-Icx8_U0f87bEluzkNMk1tCnOkuxX71C-0O9Br3MQdHp3UpCOWaCXbDzHvydnBjxg_P9Zz8vL15uPrG7n_cfb-6vGe-lvXCjIO6aaUxjRz0oHrFO2E8aCcEqMa32unad53zZSi7WgH3Brl2WHvVCGzkObk46paTfq-YFzuF7HEc3Yxxzba8L6RqVStegXJTrCsWFpQfUZ9izgkHu0thculgOdinJOzWliTsUxIWWluSKDufnuXXbsL-38Zf6wvw9Qhg8WMfMNnsA84e-5CwiPUxvCD_B_mjmFY</recordid><startdate>201510</startdate><enddate>201510</enddate><creator>He, Jian Wei</creator><creator>Bondy, Genevieve S.</creator><creator>Zhou, Ting</creator><creator>Caldwell, Don</creator><creator>Boland, Greg J.</creator><creator>Scott, Peter M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201510</creationdate><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><author>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>3-epi-DON</topic><topic>3T3 fibroblasts cell line</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>B6C3F1 mouse</topic><topic>BrdU bioassay</topic><topic>Caco-2 cell line</topic><topic>Caco-2 Cells</topic><topic>Cell Survival - drug effects</topic><topic>Crosses, Genetic</topic><topic>Cytotoxicity</topic><topic>Deoxynivalenol</topic><topic>Devosia</topic><topic>DNA - biosynthesis</topic><topic>DON</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Humans</topic><topic>Hyphomicrobiaceae - metabolism</topic><topic>Inactivation, Metabolic</topic><topic>Kinetics</topic><topic>Mice</topic><topic>MTT bioassay</topic><topic>NIH 3T3 Cells</topic><topic>Nucleic Acid Synthesis Inhibitors - administration & dosage</topic><topic>Nucleic Acid Synthesis Inhibitors - chemistry</topic><topic>Nucleic Acid Synthesis Inhibitors - metabolism</topic><topic>Nucleic Acid Synthesis Inhibitors - toxicity</topic><topic>Random Allocation</topic><topic>Stereoisomerism</topic><topic>Toxicity Tests, Subacute</topic><topic>Trichothecenes - administration & dosage</topic><topic>Trichothecenes - chemistry</topic><topic>Trichothecenes - metabolism</topic><topic>Trichothecenes - toxicity</topic><topic>Vomitoxin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Jian Wei</creatorcontrib><creatorcontrib>Bondy, Genevieve S.</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>Caldwell, Don</creatorcontrib><creatorcontrib>Boland, Greg J.</creatorcontrib><creatorcontrib>Scott, Peter M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Food and chemical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Jian Wei</au><au>Bondy, Genevieve S.</au><au>Zhou, Ting</au><au>Caldwell, Don</au><au>Boland, Greg J.</au><au>Scott, Peter M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</atitle><jtitle>Food and chemical toxicology</jtitle><addtitle>Food Chem Toxicol</addtitle><date>2015-10</date><risdate>2015</risdate><volume>84</volume><spage>250</spage><epage>259</epage><pages>250-259</pages><issn>0278-6915</issn><eissn>1873-6351</eissn><abstract>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON.
•The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26363308</pmid><doi>10.1016/j.fct.2015.09.003</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-6915 |
ispartof | Food and chemical toxicology, 2015-10, Vol.84, p.250-259 |
issn | 0278-6915 1873-6351 |
language | eng |
recordid | cdi_proquest_miscellaneous_1762369692 |
source | Elsevier |
subjects | 3-epi-DON 3T3 fibroblasts cell line Administration, Oral Animals B6C3F1 mouse BrdU bioassay Caco-2 cell line Caco-2 Cells Cell Survival - drug effects Crosses, Genetic Cytotoxicity Deoxynivalenol Devosia DNA - biosynthesis DON Dose-Response Relationship, Drug Female Humans Hyphomicrobiaceae - metabolism Inactivation, Metabolic Kinetics Mice MTT bioassay NIH 3T3 Cells Nucleic Acid Synthesis Inhibitors - administration & dosage Nucleic Acid Synthesis Inhibitors - chemistry Nucleic Acid Synthesis Inhibitors - metabolism Nucleic Acid Synthesis Inhibitors - toxicity Random Allocation Stereoisomerism Toxicity Tests, Subacute Trichothecenes - administration & dosage Trichothecenes - chemistry Trichothecenes - metabolism Trichothecenes - toxicity Vomitoxin |
title | Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A00%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxicology%20of%203-epi-deoxynivalenol,%20a%20deoxynivalenol-transformation%20product%20by%20Devosia%20mutans%2017-2-E-8&rft.jtitle=Food%20and%20chemical%20toxicology&rft.au=He,%20Jian%20Wei&rft.date=2015-10&rft.volume=84&rft.spage=250&rft.epage=259&rft.pages=250-259&rft.issn=0278-6915&rft.eissn=1873-6351&rft_id=info:doi/10.1016/j.fct.2015.09.003&rft_dat=%3Cproquest_cross%3E1762369692%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1718915278&rft_id=info:pmid/26363308&rfr_iscdi=true |